Chaitra Shankar Ujjani MD

PubMed

• Impact of immunophenotype on clinical disease characteristics and outcomes in T-cell prolymphocytic leukaemia.
  Christina Poh, Xueyan Chen, Jenna Voutsinas, Kikkeri Naresh, Jerlin J Dizon
  British Journal of Haematology. 2025-11-01
• Ibrutinib and Venetoclax in Relapsed and Refractory Follicular Lymphoma.
  Chaitra Ujjani, Hongkun Wang, Catherine Broome, Ajay K Gopal, Stephen D Smith
  Clinical Lymphoma, Myeloma & Leukemia. 2025-10-01
• Long-term follow-up of dose-dense brentuximab vedotin, ifosfamide, carboplatin and etoposide in second-line treatment of relapsed/refractory classical Hodgkin lymphoma.
  Ryan C Lynch, Ryan D Cassaday, Stephen D Smith, Andrew J Cowan, Edus H Warren
  British Journal of Haematology. 2025-10-01

Journal Articles

• Real World Outcomes and Management Strategies for Venetoclax-Treated Chronic Lymphocytic Leukemia Patients in the United States  
  Arun K Singavi, Andrew Zelenetz, Nicole Lamanna, Bruce D Cheson, Richard R Furman, Jakub Svoboda, Stephen J Schuster, John N Allan, Chaitra S Ujjani, Haematologica

Abstracts/Posters

• High Rate of Exclusion of HIV Infected Patients from Modern Lymphoma Studies: An Analysis of Current United States Therapeutic Trials
  Chaitra S. Ujjani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Toxicities and Outcomes of Acalabrutinib-Treated Patients with Chronic Lymphocytic Leukemia: A Retrospective Analysis of Real World Patients
  Chaitra S. Ujjani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Relapsed or Refractory CLL after CD19-Specific CAR-T Therapy: Treatment Patterns and Clinical Outcomes
  Chaitra S. Ujjani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Impact of Lab Abnormalities at the Time of Progression in Patients Receiving CD19-Specific CAR T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphomas
  Chaitra S. Ujjani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Treatment Sequences and Outcomes of Patients with CLL Treated with Venetoclax and Other Novel Agents Post Introduction of Novel Therapies
  Chaitra S. Ujjani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Veneto-STOP Study: Sequential Assessment of Minimal Residual Disease By Next Generation Sequencing to Optimize Outcomes and Minimize Exposure in Venetoclax-Treated CLL...
  Chaitra S. Ujjani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Treatment Discontinuation Patterns for Patients with CLL in the Real-World Settings: Results from a Multi-Center Study
  Chaitra S. Ujjani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• CD20 Targeted CAR-T for High-Risk B-Cell Non-Hodgkin Lymphomas
  Chaitra S. Ujjani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Efficacy of Therapies Following Venetoclax Discontinuation in CLL: Focus on B-Cell Receptor Signal Transduction Inhibitors and Cellular Therapies
  Chaitra Ujjani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Treatment Sequences and Outcomes of Patients with CLL Treated with Venetoclax and Other Novel Agents Post Introduction of Novel Therapies
  Chaitra S. Ujjani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Comparative Outcomes of Relapsed Follicular Lymphoma Patients Treated with Novel Agents: A Multi-Center Analysis
  Chaitra S. Ujjani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Low Achievement of End of Life Quality Measures in Large B-Cell Lymphoma Patients Who Progressed after CD19-Specific CAR-T Cell Therapy
  Chaitra S. Ujjani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Join now to see all

Lectures

• Veneto-STOP Study: Sequential Assessment of Minimal Residual Disease By Next Generation Sequencing to Optimize Outcomes and Minimize Exposure in Venetoclax-Treated CLL... 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019